Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Orphan Drugs market report explains the definition, types, applications, major countries, and major players of the Orphan Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
AstraZeneca
Pfizer
Alexion Pharmaceuticals
Eisai
Amgen
Johnson & Johnson
Daiichi Sankyo
Shire
Sanofi
Eli Lilly
Novartis
Bayer
Merck
Roche
Celgene
Biogen
Novo Nordisk
GlaxoSmithKline
Bristol-Myers Squibb
By Type:
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
By End-User:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Orphan Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Orphan Drugs Outlook to 2028- Original Forecasts
-
2.2 Orphan Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Orphan Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Orphan Drugs Market- Recent Developments
-
6.1 Orphan Drugs Market News and Developments
-
6.2 Orphan Drugs Market Deals Landscape
7 Orphan Drugs Raw Materials and Cost Structure Analysis
-
7.1 Orphan Drugs Key Raw Materials
-
7.2 Orphan Drugs Price Trend of Key Raw Materials
-
7.3 Orphan Drugs Key Suppliers of Raw Materials
-
7.4 Orphan Drugs Market Concentration Rate of Raw Materials
-
7.5 Orphan Drugs Cost Structure Analysis
-
7.5.1 Orphan Drugs Raw Materials Analysis
-
7.5.2 Orphan Drugs Labor Cost Analysis
-
7.5.3 Orphan Drugs Manufacturing Expenses Analysis
8 Global Orphan Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Orphan Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Orphan Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Orphan Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Orphan Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gastrointestinal Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pulmonary Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Hematology Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Cardio-vascular Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Metabolic disorders Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Endocrinology Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Infectious diseases Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Orphan Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Orphan Drugs Market Analysis and Outlook till 2022
-
10.1 Global Orphan Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Orphan Drugs Consumption (2017-2022)
-
10.2.2 Canada Orphan Drugs Consumption (2017-2022)
-
10.2.3 Mexico Orphan Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Orphan Drugs Consumption (2017-2022)
-
10.3.2 UK Orphan Drugs Consumption (2017-2022)
-
10.3.3 Spain Orphan Drugs Consumption (2017-2022)
-
10.3.4 Belgium Orphan Drugs Consumption (2017-2022)
-
10.3.5 France Orphan Drugs Consumption (2017-2022)
-
10.3.6 Italy Orphan Drugs Consumption (2017-2022)
-
10.3.7 Denmark Orphan Drugs Consumption (2017-2022)
-
10.3.8 Finland Orphan Drugs Consumption (2017-2022)
-
10.3.9 Norway Orphan Drugs Consumption (2017-2022)
-
10.3.10 Sweden Orphan Drugs Consumption (2017-2022)
-
10.3.11 Poland Orphan Drugs Consumption (2017-2022)
-
10.3.12 Russia Orphan Drugs Consumption (2017-2022)
-
10.3.13 Turkey Orphan Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Orphan Drugs Consumption (2017-2022)
-
10.4.2 Japan Orphan Drugs Consumption (2017-2022)
-
10.4.3 India Orphan Drugs Consumption (2017-2022)
-
10.4.4 South Korea Orphan Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Orphan Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Orphan Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Orphan Drugs Consumption (2017-2022)
-
10.4.8 Thailand Orphan Drugs Consumption (2017-2022)
-
10.4.9 Singapore Orphan Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Orphan Drugs Consumption (2017-2022)
-
10.4.11 Philippines Orphan Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Orphan Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Orphan Drugs Consumption (2017-2022)
-
10.5.2 Colombia Orphan Drugs Consumption (2017-2022)
-
10.5.3 Chile Orphan Drugs Consumption (2017-2022)
-
10.5.4 Argentina Orphan Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Orphan Drugs Consumption (2017-2022)
-
10.5.6 Peru Orphan Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Orphan Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Orphan Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Orphan Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Orphan Drugs Consumption (2017-2022)
-
10.6.3 Oman Orphan Drugs Consumption (2017-2022)
-
10.6.4 Qatar Orphan Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Orphan Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Orphan Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Orphan Drugs Consumption (2017-2022)
-
10.7.2 South Africa Orphan Drugs Consumption (2017-2022)
-
10.7.3 Egypt Orphan Drugs Consumption (2017-2022)
-
10.7.4 Algeria Orphan Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Orphan Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Orphan Drugs Consumption (2017-2022)
11 Global Orphan Drugs Competitive Analysis
-
11.1 AstraZeneca
-
11.1.1 AstraZeneca Company Details
-
11.1.2 AstraZeneca Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 AstraZeneca Orphan Drugs Main Business and Markets Served
-
11.1.4 AstraZeneca Orphan Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Orphan Drugs Main Business and Markets Served
-
11.2.4 Pfizer Orphan Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Alexion Pharmaceuticals
-
11.3.1 Alexion Pharmaceuticals Company Details
-
11.3.2 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Alexion Pharmaceuticals Orphan Drugs Main Business and Markets Served
-
11.3.4 Alexion Pharmaceuticals Orphan Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eisai
-
11.4.1 Eisai Company Details
-
11.4.2 Eisai Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eisai Orphan Drugs Main Business and Markets Served
-
11.4.4 Eisai Orphan Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Amgen
-
11.5.1 Amgen Company Details
-
11.5.2 Amgen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Amgen Orphan Drugs Main Business and Markets Served
-
11.5.4 Amgen Orphan Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Johnson & Johnson
-
11.6.1 Johnson & Johnson Company Details
-
11.6.2 Johnson & Johnson Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Johnson & Johnson Orphan Drugs Main Business and Markets Served
-
11.6.4 Johnson & Johnson Orphan Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Daiichi Sankyo
-
11.7.1 Daiichi Sankyo Company Details
-
11.7.2 Daiichi Sankyo Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Daiichi Sankyo Orphan Drugs Main Business and Markets Served
-
11.7.4 Daiichi Sankyo Orphan Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Shire
-
11.8.1 Shire Company Details
-
11.8.2 Shire Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Shire Orphan Drugs Main Business and Markets Served
-
11.8.4 Shire Orphan Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sanofi
-
11.9.1 Sanofi Company Details
-
11.9.2 Sanofi Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sanofi Orphan Drugs Main Business and Markets Served
-
11.9.4 Sanofi Orphan Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Eli Lilly
-
11.10.1 Eli Lilly Company Details
-
11.10.2 Eli Lilly Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Eli Lilly Orphan Drugs Main Business and Markets Served
-
11.10.4 Eli Lilly Orphan Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Orphan Drugs Main Business and Markets Served
-
11.11.4 Novartis Orphan Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bayer
-
11.12.1 Bayer Company Details
-
11.12.2 Bayer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bayer Orphan Drugs Main Business and Markets Served
-
11.12.4 Bayer Orphan Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Merck
-
11.13.1 Merck Company Details
-
11.13.2 Merck Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Merck Orphan Drugs Main Business and Markets Served
-
11.13.4 Merck Orphan Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Roche
-
11.14.1 Roche Company Details
-
11.14.2 Roche Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Roche Orphan Drugs Main Business and Markets Served
-
11.14.4 Roche Orphan Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Celgene
-
11.15.1 Celgene Company Details
-
11.15.2 Celgene Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Celgene Orphan Drugs Main Business and Markets Served
-
11.15.4 Celgene Orphan Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Biogen
-
11.16.1 Biogen Company Details
-
11.16.2 Biogen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Biogen Orphan Drugs Main Business and Markets Served
-
11.16.4 Biogen Orphan Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Novo Nordisk
-
11.17.1 Novo Nordisk Company Details
-
11.17.2 Novo Nordisk Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Novo Nordisk Orphan Drugs Main Business and Markets Served
-
11.17.4 Novo Nordisk Orphan Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 GlaxoSmithKline
-
11.18.1 GlaxoSmithKline Company Details
-
11.18.2 GlaxoSmithKline Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 GlaxoSmithKline Orphan Drugs Main Business and Markets Served
-
11.18.4 GlaxoSmithKline Orphan Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Bristol-Myers Squibb
-
11.19.1 Bristol-Myers Squibb Company Details
-
11.19.2 Bristol-Myers Squibb Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Bristol-Myers Squibb Orphan Drugs Main Business and Markets Served
-
11.19.4 Bristol-Myers Squibb Orphan Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Orphan Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Orphan Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Cardio-vascular Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Orphan Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Orphan Drugs Market Analysis and Outlook to 2028
-
13.1 Global Orphan Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Orphan Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Orphan Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Orphan Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Orphan Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Orphan Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Orphan Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Orphan Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Orphan Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Orphan Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Orphan Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Orphan Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Orphan Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Orphan Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Orphan Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Orphan Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Orphan Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Orphan Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Orphan Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Orphan Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Orphan Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Orphan Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Orphan Drugs
-
Figure of Orphan Drugs Picture
-
Table Global Orphan Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Orphan Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardio-vascular Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Endocrinology Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Orphan Drugs Consumption by Country (2017-2022)
-
Table North America Orphan Drugs Consumption by Country (2017-2022)
-
Figure United States Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Orphan Drugs Consumption by Country (2017-2022)
-
Figure Germany Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Orphan Drugs Consumption by Country (2017-2022)
-
Figure China Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Orphan Drugs Consumption by Country (2017-2022)
-
Figure Brazil Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Orphan Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Orphan Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Orphan Drugs Consumption by Country (2017-2022)
-
Figure Australia Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Orphan Drugs Consumption and Growth Rate (2017-2022)
-
Table AstraZeneca Company Details
-
Table AstraZeneca Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Orphan Drugs Main Business and Markets Served
-
Table AstraZeneca Orphan Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Orphan Drugs Main Business and Markets Served
-
Table Pfizer Orphan Drugs Product Portfolio
-
Table Alexion Pharmaceuticals Company Details
-
Table Alexion Pharmaceuticals Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals Orphan Drugs Main Business and Markets Served
-
Table Alexion Pharmaceuticals Orphan Drugs Product Portfolio
-
Table Eisai Company Details
-
Table Eisai Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Orphan Drugs Main Business and Markets Served
-
Table Eisai Orphan Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Orphan Drugs Main Business and Markets Served
-
Table Amgen Orphan Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Orphan Drugs Main Business and Markets Served
-
Table Johnson & Johnson Orphan Drugs Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Orphan Drugs Main Business and Markets Served
-
Table Daiichi Sankyo Orphan Drugs Product Portfolio
-
Table Shire Company Details
-
Table Shire Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Orphan Drugs Main Business and Markets Served
-
Table Shire Orphan Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Orphan Drugs Main Business and Markets Served
-
Table Sanofi Orphan Drugs Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Orphan Drugs Main Business and Markets Served
-
Table Eli Lilly Orphan Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Orphan Drugs Main Business and Markets Served
-
Table Novartis Orphan Drugs Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Orphan Drugs Main Business and Markets Served
-
Table Bayer Orphan Drugs Product Portfolio
-
Table Merck Company Details
-
Table Merck Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Orphan Drugs Main Business and Markets Served
-
Table Merck Orphan Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Orphan Drugs Main Business and Markets Served
-
Table Roche Orphan Drugs Product Portfolio
-
Table Celgene Company Details
-
Table Celgene Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Orphan Drugs Main Business and Markets Served
-
Table Celgene Orphan Drugs Product Portfolio
-
Table Biogen Company Details
-
Table Biogen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Orphan Drugs Main Business and Markets Served
-
Table Biogen Orphan Drugs Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Orphan Drugs Main Business and Markets Served
-
Table Novo Nordisk Orphan Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Orphan Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Orphan Drugs Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Orphan Drugs Main Business and Markets Served
-
Table Bristol-Myers Squibb Orphan Drugs Product Portfolio
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardio-vascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Orphan Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)
-
